CG Oncology, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGON and other ETFs, options, and stocks.About CGON
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC).
CEOArthur Kuan
CEOArthur Kuan
Employees113
Employees113
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2010
Founded2010
Employees113
Employees113
CGON Key Statistics
Market cap2.00B
Market cap2.00B
Price-Earnings ratio-18.92
Price-Earnings ratio-18.92
Dividend yield—
Dividend yield—
Average volume1.44M
Average volume1.44M
High today$28.06
High today$28.06
Low today$25.50
Low today$25.50
Open price$26.10
Open price$26.10
Volume1.17M
Volume1.17M
52 Week high$40.47
52 Week high$40.47
52 Week low$14.80
52 Week low$14.80
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own CGON. This list is generated using Robinhood data, and it’s not a recommendation.